Bioventus (BVS) Net Income towards Common Stockholders (QoQ) (2020 - 2026)
Powered by 
Analysis
Bioventus (BVS) Net Income towards Common Stockholders (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn |
| 10 | Bioventus | 923.70 Mn | 894.24 Mn | 105.67 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 27, 2026 | 817.51% |
| Mar 28, 2026 | -77.21% |
| Dec 31, 2025 | 332.30% |
| Sep 27, 2025 | -56.79% |
| Jun 28, 2025 | 379.11% |
| Mar 29, 2025 | -450.91% |
| Dec 31, 2024 | 89.69% |
| Sep 28, 2024 | 82.91% |
| Jun 29, 2024 | -436.23% |
| Mar 30, 2024 | 16.65% |
| Dec 31, 2023 | 12.91% |
| Sep 30, 2023 | -85.82% |
| Jul 1, 2023 | 97.29% |
| Apr 1, 2023 | -288.76% |
| Dec 31, 2022 | 69.20% |
| Oct 1, 2022 | -1,718.04% |
| Jul 2, 2022 | 45.87% |
| Apr 2, 2022 | -59,124.00% |
| Dec 31, 2021 | 98.90% |
| Oct 2, 2021 | 78.95% |